US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ENvue Medical, Inc

3.39

-0.1575-4.44%

Volume:12.62K

Turnover:44.30K

Market Cap:3.69M

PE:-0.11

High:3.77

Open:3.67

Low:3.27

Close:3.55

52wk High:162.50

52wk Low:3.27

Shares:1.09M

Float Shares:1.09M

Volume Ratio:0.43

T/O Rate:1.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-32.1906

EPS(LYR):-137.2985

ROE:-30.51%

ROA:-19.99%

PB:0.09

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Envue Medical Receives Initial UroShield Kit Order From Peak Medical in UK

BRIEF-Envue Medical Appoints Veteran David Johnson as Chairman

Envue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman

THOMSON REUTERS

NanoVibronix Inc. Held Annual Shareholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FEED"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FEED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FEED\",,,,,undefined,":{"symbol":"FEED","market":"US","secType":"STK","nameCN":"ENvue Medical, Inc","latestPrice":3.3925,"timestamp":1766005200000,"preClose":3.55,"halted":0,"volume":12620,"delay":0,"floatShares":1088100,"shares":1088176,"eps":-32.190582,"marketStatus":"Pre-Mkt","change":-0.1575,"latestTime":"12-18 09:23:25 EST","open":3.665,"high":3.7662,"low":3.27,"amount":44302.451948,"amplitude":0.139775,"askPrice":4.9,"askSize":1000,"bidPrice":2.63,"bidSize":900,"shortable":3,"etf":0,"ttmEps":-32.190582,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766068200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":3.26,"postHourTrading":{"tag":"盘后","latestPrice":3.34,"preClose":3.3925,"latestTime":"19:32 EST","volume":444,"amount":1480.9782,"timestamp":1766017957833},"volumeRatio":0.42924639778871426},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FEED\",,,,,undefined,":{"symbol":"FEED","floatShares":1088100,"roa":"-19.99%","roe":"-30.51%","lyrEps":-137.298499,"volumeRatio":0.42924639778871426,"shares":1088176,"dividePrice":0,"high":3.7662,"amplitude":0.139775,"preClose":3.55,"low":3.27,"week52Low":3.27,"pbRate":"0.09","psRate":"1.37","week52High":162.5,"institutionHeld":0,"latestPrice":3.3925,"committee":-0.052632,"eps":-32.190582,"divideRate":0,"volume":12620,"delay":0,"ttmEps":-32.190582,"open":3.665,"prevYearClose":64.9,"prevWeekClose":4.1,"prevMonthClose":4.13,"prevQuarterClose":5.64,"fiveDayClose":4.31,"twentyDayClose":4.32,"sixtyDayClose":6.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FEED\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FEED\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FEED\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FEED\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FEED","date":"2025-12-17","current":-0.105388,"percent":1,"low":-0.659598,"twenty":-0.644797,"median":-0.622596,"eighty":-0.591707,"high":-0.571115,"avg":-0.61777,"sd":0.036284,"marketCap":3863024},"quantilePoints":[{"date":"2025-12-17","current":-0.571115,"twenty":-0.644797,"median":-0.622596,"eighty":-0.591707,"marketCap":3863024}],"updateTime":1766058506362},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FEED\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592901455","title":"Envue Medical Receives Initial UroShield Kit Order From Peak Medical in UK","url":"https://stock-news.laohu8.com/highlight/detail?id=2592901455","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592901455?lang=en_us&edition=fundamental","pubTime":"2025-12-18 22:01","pubTimestamp":1766066512,"startTime":"0","endTime":"0","summary":"Envue Medical Inc. has announced that its UroShield Kit has been added to the UK National Health Service  Drug Tariff Part IX, enabling nationwide prescription reimbursement across the UK. Following this reimbursement milestone, Envue Medical has received an initial purchase order from Peak Medical, a UK-based distributor specializing in stoma care and urology medical devices. This order reflects early commercial demand after the UroShield Kit's inclusion in the NHS Drug Tariff. The agreement is expected to support the product’s adoption in both hospital and community care settings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envue Medical Inc. published the original content used to generate this news brief via GlobeNewswire  on Dec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL6gTV8z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2210150020.SGD","NDAQ","BK4112","BK4585","IE00B3QW5Z07.USD","SG9999014021.USD","LU2095319765.USD","BK4588","LU2210149790.SGD","IE00BGHQF748.EUR","FEED","SG9999014013.SGD","SG9999014005.SGD","BK4082","IE00B64PRP62.GBP","LU0314104364.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2591905628","title":"BRIEF-Envue Medical Appoints Veteran David Johnson as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2591905628","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591905628?lang=en_us&edition=fundamental","pubTime":"2025-12-16 00:12","pubTimestamp":1765815160,"startTime":"0","endTime":"0","summary":"BRIEF-Envue Medical Appoints Veteran David Johnson as ChairmanDec 15 (Reuters) - ENvue Medical, Inc FEED.O:ENVUE MEDICAL APPOINTS VETERAN HEALTHCARE-INDUSTRY EXECUTIVE, DAVID JOHNSON, AS CHAIRMANSource text: ID:nBw81pJz4aFurther company coverage: FEED.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA5LWXZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEED","BK4082"],"gpt_icon":0},{"id":"2591644612","title":"Envue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2591644612","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591644612?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:00","pubTimestamp":1765807205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA5LWXZN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","FEED"],"gpt_icon":0},{"id":"2589481899","title":"NanoVibronix Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2589481899","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589481899?lang=en_us&edition=fundamental","pubTime":"2025-12-05 19:15","pubTimestamp":1764933357,"startTime":"0","endTime":"0","summary":"NanoVibronix Inc. held its Annual Meeting of Stockholders on October 30, 2025. Shareholders elected five nominees to the Board of Directors. The meeting also included a proposal to approve the First Amendment to the 2024 Long-Term Incentive Plan, which was approved. In addition, shareholders approved the issuance of shares of Common Stock underlying convertible preferred stock and warrants issued in a private placement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoVibronix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the infor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL2yntbc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAOV","BK4082","FEED"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/FEED\",params:#limit:6,delay:false,,,undefined,":[]}}